ImmunoPrecise (NAS: $IPA), Sekur Private Data (OTC
Post# of 1354
(Total Views: 184)
Posted On: 06/24/2023 11:07:34 AM
ImmunoPrecise (NAS: $IPA), Sekur Private Data (OTCQX: $SWISF) and Pressure BioSciences (OTCQCB: $PBIO) Featured on Newsmax and Fox Business
https://thestreetreports.com/immunoprecise-na...-business/
New to the Street, which is produced by FMW Media, is currently one of the more popular shows among investors, analysts, and market watchers. It features in-depth interviews with top executives of many companies and provides highly valuable information.
On June 17, three companies were featured on the show, namely ImmunoPrecise Antibodies Ltd (NAS:IPA), Sekur Private Data Ltd (OTCQX: SWISF) (SKUR.C), and Pressure BioSciences Inc (OTCQCB: PBIO). In light of the development, it may be a good idea for investors to perhaps have a look into some of the highlights of the discussions which took place. The show was featured on both Newsmax and Fox Business, two highly popular networks.
The President and Chief Executive Officer of ImmunoPrecise Antibodies Dr. Jennifer Bath went to the interview. The company is best known for providing artificial intelligence-powered drug discovery solutions which are used by many companies. Dr. Bath spoke at the interview about BioStrand, the company’s subsidiary, and how it was helping the company further advance its artificial intelligence-powered Biotherapeutic research and technology solutions. It was further noted that the company had attracted clients because of the advanced artificial intelligence solutions that it offers.
The President and Chief Executive Officer of Pressure BioSciences Inc Richard T Schumacher represented the company at the interview. He spoke about the company’s business of development and sales of innovative high-pressure-based platform technology solutions which are meant for the worldwide life sciences industry. Its revenues are mainly generated through patented platforms like Ultra Shear Technology, Pressure Cycling Technology, and BaroFold Platform. The platforms involve the deployment of both high-pressure as well as high shearing.
Internationally famed internet privacy expert and the Chief Executive Officer of Sekur Private Data Ltd Alain Ghiai was the interviewee for the company. The interview was focussed on the recent hacking of the German government systems which granted access to private government data and sensitive information. Ghiai noted that such events were not only specific to Germany but happened worldwide. The use of 3rd party IT contractors had led to the hacking and that was the reason it happened so frequently.
https://thestreetreports.com/immunoprecise-na...-business/
New to the Street, which is produced by FMW Media, is currently one of the more popular shows among investors, analysts, and market watchers. It features in-depth interviews with top executives of many companies and provides highly valuable information.
On June 17, three companies were featured on the show, namely ImmunoPrecise Antibodies Ltd (NAS:IPA), Sekur Private Data Ltd (OTCQX: SWISF) (SKUR.C), and Pressure BioSciences Inc (OTCQCB: PBIO). In light of the development, it may be a good idea for investors to perhaps have a look into some of the highlights of the discussions which took place. The show was featured on both Newsmax and Fox Business, two highly popular networks.
The President and Chief Executive Officer of ImmunoPrecise Antibodies Dr. Jennifer Bath went to the interview. The company is best known for providing artificial intelligence-powered drug discovery solutions which are used by many companies. Dr. Bath spoke at the interview about BioStrand, the company’s subsidiary, and how it was helping the company further advance its artificial intelligence-powered Biotherapeutic research and technology solutions. It was further noted that the company had attracted clients because of the advanced artificial intelligence solutions that it offers.
The President and Chief Executive Officer of Pressure BioSciences Inc Richard T Schumacher represented the company at the interview. He spoke about the company’s business of development and sales of innovative high-pressure-based platform technology solutions which are meant for the worldwide life sciences industry. Its revenues are mainly generated through patented platforms like Ultra Shear Technology, Pressure Cycling Technology, and BaroFold Platform. The platforms involve the deployment of both high-pressure as well as high shearing.
Internationally famed internet privacy expert and the Chief Executive Officer of Sekur Private Data Ltd Alain Ghiai was the interviewee for the company. The interview was focussed on the recent hacking of the German government systems which granted access to private government data and sensitive information. Ghiai noted that such events were not only specific to Germany but happened worldwide. The use of 3rd party IT contractors had led to the hacking and that was the reason it happened so frequently.
(0)
(0)Pressure Biosciences (PBIO) Stock Research Links
Scroll down for more posts ▼